Clinical Trials Directory

Trials / Completed

CompletedNCT03679533

The Impact of Cranberries On the Microbiome and the Brain in Healthy Ageing sTudy (COMBAT)

The Impact of Cranberries on the Microbiome and the Brain in Healthy Ageing: A Feasibility Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of East Anglia · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

Tremendous progress has been made in characterizing the interactions between the central nervous system and the gastrointestinal tract. This concept of a gut-brain axis suggests that influencing bacteria in the gut is a promising approach for developing new ways of benefiting brain function. This is particularly relevant for an ageing population for which cognitive decline is a common symptom and can be an indicator for the development of neurodegenerative conditions such as dementia. There is good evidence already that nutrition can delay the development of cognitive decline in ageing, in particular for ageing-sensitive brain regions such as the medial temporal lobe, however this has been little explored for cranberry intake. Cranberries are high in plant-derived nutrients called polyphenols, which have been suggested to promote brain function and protect against disease-causing mechanisms. In the proposed project we will pioneer work to investigate the impact of cranberry intake on gut bacteria and how it relates to cognitive performance in ageing and associated regions in the brain. This study is being conducted by Chief Investigators Dr David Vauzour and Prof Michael Hornberger at the University of East Anglia. Sixty participants (i.e. n=30 control and treatment groups) aged 50-80 years old, with no memory complaints will be recruited for this 12-week double-blind placebo-controlled parallel intervention of cranberry flavonoids. Freeze-dried cranberry or a matched placebo will be taken twice daily for the duration of the trial. Blood, urine and faecal samples will be collected for microbiome, DNA, biochemical and nutritional analysis. Participants will also undergo cognitive testing, as well as MRI scanning to detect changes in brain physiology.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFreeze-Dried Cranberry PowderFreeze-dried cranberry powder (or matched placebo), approximating 500mg active flavonoids per day, taken twice daily for 12 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo food powder matched for taste, colour, energy and macronutrient content to the active cranberry powder.

Timeline

Start date
2018-10-02
Primary completion
2020-05-22
Completion
2020-05-22
First posted
2018-09-20
Last updated
2020-09-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03679533. Inclusion in this directory is not an endorsement.